Galvani E, Mundra P, Valpione S, et al. Low tumour heterogeneity but not mutational burden correlates with response to anti-PD-1 treatment in a mouse model of melanoma. SMR 2017, abstract SMR4-04.
Durvalumab na chemoradiotherapie bij stadium III niet-kleincellig longcarcinoom
aug 2018 | Longoncologie